Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF)
- PMID: 10584990
Studies of glomerular permeability factor (GPF) in focal segmental glomerular sclerosis and the relationship between GPF and vascular permeability factor (VPF)
Abstract
Background: We previously demonstrated that the supernatants of cultured concanavalin-A (con-A) stimulated peripheral blood mononuclear cells (PBMC) from patients with minimal change nephrotic syndrome (MCNS) increased the urinary protein excretion in injected rats and suggested that PBMC released a factor, which we called glomerular permeability factor (GPF), changes in the glomerular permeability and thus resulted in proteinuria in MCNS.
Material and methods: In this study we investigated the GPF activity in focal segmental glomerular sclerosis (FGS) and other conditions of chronic glomerulonephritis (CGN), and also the relationship between GPF and vascular permeability factor (VPF). In experiment 1 the supernatants of the cultured con-A stimulated PBMC from patients with 10 FGS, 5 other CGN and 10 controls were tested regarding their ability to produce GPE The GPF activity was defined as positive when the 8-hour urinary protein excretion after the injection of the supernatant in Sprague-Dawley rats exceeded the mean value plus 2 standard deviations (M + 2 SD) of that before injection.
Results: Three out of 10 FGS patients and 1 membranous nephropathy patient out of the 5 other CGN patients were positive for GPF activity. In experiment 2 the relationship between GPF and VPF was analyzed using culture supernatants of PBMC from 10 nephrotic MCNS patients and 15 controls. The VPF activity was measured following the method developed by Ovary [1975]. All 7 cases that were positive for GPF activity were simultaneously positive for VPF activity. On the other hand, 16 cases that were positive for VPF activity were not always positive for GPF activity (7 cases were positive and 9 were negative for VPF activity).
Conclusion: Experiments 1 and 2 thus suggested that GPF was not active in MCNS alone, but also in other CGN conditions and it was therefore not considered to be the same factor/substance(s) as VPF.
Similar articles
-
Interleukin-15 and interleukin-12 have an additive effect on the release of vascular permeability factor by peripheral blood mononuclear cells in normals and in patients with nephrotic syndrome.Clin Nephrol. 1999 Jul;52(1):10-8. Clin Nephrol. 1999. PMID: 10442490
-
Vascular permeability increasing factor (VPF) in IgA nephropathy.Clin Nephrol. 1982 Oct;18(4):165-7. Clin Nephrol. 1982. PMID: 7140031
-
Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome.Clin Nephrol. 2001 Apr;55(4):269-74. Clin Nephrol. 2001. PMID: 11334311
-
Pathophysiology of minimal change nephrotic syndrome and focal segmental glomerulosclerosis.Nephrology (Carlton). 2007 Dec;12 Suppl 3:S11-4. doi: 10.1111/j.1440-1797.2007.00875.x. Nephrology (Carlton). 2007. PMID: 17995521 Review.
-
Humoral permeability factors in the nephrotic syndrome: a compendium and prospectus.J Nephrol. 2001 Nov-Dec;14 Suppl 4:S48-50. J Nephrol. 2001. PMID: 11798145 Review.
Cited by
-
Minimal change nephropathy and focal segmental glomerulosclerosis.Semin Immunopathol. 2007 Nov;29(4):415-26. doi: 10.1007/s00281-007-0094-z. Epub 2007 Oct 23. Semin Immunopathol. 2007. PMID: 17955243 Review.
-
Serum immunoglobulin G, M and IgG:IgM ratio as predictors for outcome of childhood nephrotic syndrome.World J Pediatr. 2009 May;5(2):127-31. doi: 10.1007/s12519-009-0025-2. Epub 2009 Jul 9. World J Pediatr. 2009. PMID: 19718535